To amend title III of the Public Health Service Act to terminate the effective time period for immunity for manufacturers of COVID-19 vaccines, and for other purposes.

Bill: 117-hr-6106
Sponsor: full_name: Rep. Gooden, Lance [R-TX-5]
Introduced: 2021-12-01
Policy area: Health
Subjects: Cardiovascular and respiratory health

Civil actions and liability

Drug safety, medical device, and laboratory regulation

Emergency medical services and trauma care

Immunology and vaccination

Infectious and parasitic diseases

Manufacturing
Latest action: action_date: 2021-12-02
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2021-12-01
action_desc: Introduced in House
text: <p>This bill terminates on December 1, 2021, certain protections from liability that apply to manufacturers of COVID-19 vaccines. Currently, the liability protections generally expire on October 1, 2024, unless the underlying declaration of emergency is rescinded earlier.</p>

tv_txt: I 117th CONGRESS 1st Session H. R. 6106 IN THE HOUSE OF REPRESENTATIVES December 1, 2021 Mr. Gooden of Texas introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend title III of the Public Health Service Act to terminate the effective time period for immunity for manufacturers of COVID–19 vaccines, and for other purposes.

1. Liability of COVID–19 vaccine manufacturers Notwithstanding any other provision of law, in applying section XII of the Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID–19 issued pursuant to section 319F–3(b)(2)(B) of the Public Health Service Act (42 U.S.C. 247d–6d(b)(2)(B)), with respect to manufacturers of COVID–19 vaccines, the reference to October 1, 2024, shall be deemed a reference to December 1, 2021.